A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)
Clinical trial NCT05123703 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05123703
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2025-06-09
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.